Cargando…
Quality by Design Approach for Development and Characterisation of Solid Lipid Nanoparticles of Quetiapine Fumarate
BACKGROUND: Quetiapine fumarate, a 2(nd) generation anti-psychotic drug has oral bioavailability of 9% because of hepatic first pass metabolism. Reports suggest that co-administration of drugs with lipids affects their absorption pathways, enhances lymphatic transport thus bypassing hepatic first-pa...
Autores principales: | Agarwal, Shweta, Murthy, Rayasa S. Ramachandra, Harikumar, Sasidharan Leelakumari, Garg, Rajeev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967136/ https://www.ncbi.nlm.nih.gov/pubmed/31429691 http://dx.doi.org/10.2174/1573409915666190722122827 |
Ejemplares similares
-
Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability
por: Narala, Arjun, et al.
Publicado: (2013) -
Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan
por: Jaiswal, Parul, et al.
Publicado: (2014) -
Formulation Design and Optimization of Orodispersible Tablets of Quetiapine Fumarate by Sublimation Method
por: Kalyankar, P., et al.
Publicado: (2015) -
The management of schizophrenia: focus on extended-release quetiapine fumarate
por: Peuskens, Joseph
Publicado: (2011) -
Branch retinal vein occlusion associated with quetiapine fumarate
por: Yong, Ku Chui, et al.
Publicado: (2011)